Items where Author is "Weber, R."

2013

Conen, A. and Wang, Q. and Glass, T. R. and Fux, C. A. and Thurnheer, M. C. and Orasch, C. and Calmy, A. and Bernasconi, E. and Vernazza, P. and Weber, R. and Bucher, H. C. and Battegay, M. and Fehr, J.. (2013) Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 64 (5). pp. 472-478.

Nuesch, R. and Wang, Q. and Elzi, L. and Bernasconi, E. and Weber, R. and Cavassini, M. and Vernazza, P. and Thurnheer, M. C. and Calmy, A. and Battegay, M. and Bucher, H. C. and Swiss, H. I. V. Cohort Study. (2013) Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). Journal of Acquired Immune Deficiency Syndromes, 62 (4). pp. 396-404.

2012

Thierfelder, C. and Weber, R. and Elzi, L. and Furrer, H. and Cavassini, M. and Calmy, A. and Bernasconi, E. and Gutmann, C. and Ledergerber, B. and Swiss HIV Cohort Study Group, . (2012) Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV medicine, Vol. 13. pp. 118-126.

2011

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2011) Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical Infectious Diseases, Vol. 52, H. 4. pp. 532-539.

Schüpbach, Jörg and Bisset, Leslie R. and Regenass, Stephan and Bürgisser, Philippe and Gorgievski, Meri and Steffen, Ingrid and Andreutti, Corinne and Martinetti, Gladys and Shah, Cyril and Yerly, Sabine and Klimkait, Thomas and Gebhardt, Martin and Schöni-Affolter, Franziska and Rickenbach, Martin and Swiss HIV Cohort Study, and Barth, J. and Battegay, M. and Bernascon, E. and Böni, J. and Bucher, H. C. and Bürgisser, P. and Burton-Jeangros, C. and Calmy, A. and Cavassini, M. and Dubs, R. and Egger, M. and Elzi, L. and Fehr, J. and Fischer, M. and Flepp, M. and Francioli, P. and Furrer, H. and Fux, C. A. and Gorgievski, M. and Günthard, H. and Hasse, B. and Hirsch, H. H. and Hirschel, B. and Hösli, I. and Kahlert, C. and Kaiser, L. and Keiser, O. and Kind, C. and Klimkait, T. and Kovari, H. and Ledergerber, B. and Martinetti, G. and Martinez de Tejada, B. and Müller, N. and Nadal, D. and Pantaleo, G. and Rauch, A. and Regenass, S. and Rickenbach, M. and Rudin, C. and Schmid, P. and Schultze, D. and Schöni-Affolter, F. and Schüpbach, J. and Speck, R. and Taffé, P. and Telenti, A. and Trkola, A. and Vernazza, P. and von Wyl, V. and Weber, R. and Yerly, S.. (2011) High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC infectious diseases, Vol. 11 , 254. p. 254.

Ledergerber, B. and Cavassini, M. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Furrer, H. and Rickenbach, M. and Weber, R. and Swiss HIV Cohort Study, . (2011) Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 279-288.

2010

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2010) Ambiguity in population-based sequencing of HIV-1 as a marker for the age of HIV infection. Antiviral therapy, Vol. 15 , A158-A158.

2009

Bellini, C. and Keiser, O. and Chave, J. P. and Evison, J. and Fehr, J. and Kaiser, L. and Weber, R. and Vernazza, P. and Bernasconi, E. and Telenti, A. and Cavassini, M. and Swiss, HIV Cohort Study. (2009) Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients : the Swiss HIV cohort study. HIV medicine : the official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS), Vol. 10. pp. 12-18.

2008

Khanna, N. and Opravil, M. and Furrer, H. and Cavassini, M. and Vernazza, P. and Bernasconi, E. and Weber, R. and Hirschel, B. and Battegay, M. and Kaufmann, G. R. and Swiss, HIV Cohort Study. (2008) CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical Infectious Diseases, Vol. 47. pp. 1093-1101.

Wolbers, M. and Bucher, H. C. and Furrer, H. and Rickenbach, M. and Cavassini, M. and Weber, R. and Schmid, P. and Bernasconi, E. and Hirschel, B. and Battegay, M. and Swiss, HIV Cohort Study. (2008) Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV medicine, Vol. 9. pp. 397-405.

Vo, T. T. and Ledergerber, B. and Keiser, O. and Hirschel, B. and Furrer, H. and Battegay, M. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Weber, R. and Swiss, HIV Cohort Study. (2008) Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. Journal of Infectious Diseases, Vol. 197, no. 12. pp. 1685-1694.

Garbino, J. and Inoubli, S. and Mossdorf, E. and Weber, R. and Tamm, M. and Soccal, P. and Aubert, J. D. and Bridevaux, P. O. and Tapparel, C. and Kaiser, L. and the Swiss HIV Cohort Study, . (2008) Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection. AIDS, Vol. 22. pp. 701-705.

Glass, T. R. and De Geest, S. and Hirschel, B. and Battegay, M. and Furrer, H. and Covassini, M. and Vernazza, P. L. and Bernasconi, E. and Rickenboch, M. and Weber, R. and Bucher, H. C. and Swiss, HIV Cohort Study. (2008) Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy, Vol. 13. pp. 77-85.